• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液中 D-氨基酸氧化酶与 D-氨基酸水平与认知衰老的关系。

Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging.

机构信息

Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.

出版信息

Sci Rep. 2017 Nov 1;7(1):14849. doi: 10.1038/s41598-017-13951-7.

DOI:10.1038/s41598-017-13951-7
PMID:29093468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5665939/
Abstract

Feasible peripheral biomarker for Alzheimer's disease (AD) is lacking. Dysregulation of N-methyl-D-aspartate (NMDA) receptor is implicated in the pathogenesis of AD. D-amino acid oxidase (DAO) and amino acids can regulate the NMDA receptor function. This study aimed to examine whether peripheral DAO and amino acids levels are characteristic of age-related cognitive decline. We enrolled 397 individuals (including amnestic mild cognitive impairment (MCI), mild AD, moderate to severe AD, and healthy elderly). DAO levels in the serum were measured using ELISA. Amino acids levels in serum were measured by high performance liquid chromatography. Severity of the cognitive deficits in subjects was assessed using Clinical Dementia Rating Scale (CDR). The DAO levels increased with the severity of the cognitive deficits. DAO levels were significantly associated with D-glutamate and D-serine levels. The Receiver Operating Characteristics analysis of DAO levels for AD patients vs. healthy controls determined the optimal cutoff value, 30.10, with high sensitivity (0.842) and specificity (0.889) (area under curve = 0.928). This is the first study indicating that the peripheral DAO levels may increase with age-related cognitive decline. The finding supports the hypofunction of NMDA receptor hypothesis in AD. Whether DAO could serve as a potential surrogate biomarker needs further studies.

摘要

目前缺乏阿尔茨海默病(AD)的可行外周生物标志物。N-甲基-D-天冬氨酸(NMDA)受体的失调与 AD 的发病机制有关。D-氨基酸氧化酶(DAO)和氨基酸可以调节 NMDA 受体功能。本研究旨在探讨外周 DAO 和氨基酸水平是否与年龄相关的认知能力下降有关。我们纳入了 397 名个体(包括遗忘型轻度认知障碍(MCI)、轻度 AD、中度至重度 AD 和健康老年人)。使用 ELISA 测定血清中的 DAO 水平。通过高效液相色谱法测定血清中氨基酸水平。使用临床痴呆评定量表(CDR)评估受试者认知缺陷的严重程度。DAO 水平随认知缺陷的严重程度而升高。DAO 水平与 D-谷氨酸和 D-丝氨酸水平显著相关。DAO 水平对 AD 患者与健康对照组的受试者工作特征分析确定了最佳截断值为 30.10,具有较高的敏感性(0.842)和特异性(0.889)(曲线下面积= 0.928)。这是第一项表明外周 DAO 水平可能随年龄相关的认知能力下降而升高的研究。这一发现支持 NMDA 受体功能低下假说在 AD 中的作用。DAO 是否可以作为潜在的替代生物标志物需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0891/5665939/1d39621b0811/41598_2017_13951_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0891/5665939/e014179a18cf/41598_2017_13951_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0891/5665939/1d39621b0811/41598_2017_13951_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0891/5665939/e014179a18cf/41598_2017_13951_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0891/5665939/1d39621b0811/41598_2017_13951_Fig2_HTML.jpg

相似文献

1
Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging.血液中 D-氨基酸氧化酶与 D-氨基酸水平与认知衰老的关系。
Sci Rep. 2017 Nov 1;7(1):14849. doi: 10.1038/s41598-017-13951-7.
2
Blood D-Amino Acid Oxidase Levels Increased With Cognitive Decline Among People With Mild Cognitive Impairment: A Two-Year Prospective Study.轻度认知障碍人群中,随着认知能力下降,血液 D-氨基酸氧化酶水平升高:一项为期两年的前瞻性研究。
Int J Neuropsychopharmacol. 2022 Aug 16;25(8):660-665. doi: 10.1093/ijnp/pyac027.
3
Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.血浆谷氨酸水平检测轻度认知障碍和阿尔茨海默病:机器学习方法。
J Psychopharmacol. 2021 Mar;35(3):265-272. doi: 10.1177/0269881120972331. Epub 2021 Feb 15.
4
D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment.D-谷氨酸、D-丝氨酸和 D-丙氨酸在阿尔茨海默病或轻度认知障碍患者认知能力下降中的作用不同。
Pharmacol Biochem Behav. 2019 Oct;185:172760. doi: 10.1016/j.pbb.2019.172760. Epub 2019 Aug 15.
5
pLG72 levels increase in early phase of Alzheimer's disease but decrease in late phase.pLG72 水平在阿尔茨海默病的早期阶段增加,但在晚期阶段减少。
Sci Rep. 2019 Sep 13;9(1):13221. doi: 10.1038/s41598-019-49522-1.
6
Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline.NMDA 受体功能低下和氧化应激与认知能力下降的差异关系。
Psychiatry Res. 2023 Aug;326:115288. doi: 10.1016/j.psychres.2023.115288. Epub 2023 Jun 10.
7
D-serine and D-amino acid oxidase levels in patients with schizophrenia spectrum disorders in the first episode and 6-month follow-up.首发精神分裂症谱系障碍患者及 6 个月随访时 D-丝氨酸和 D-氨基酸氧化酶水平。
J Psychiatr Res. 2024 Jul;175:123-130. doi: 10.1016/j.jpsychires.2024.05.004. Epub 2024 May 3.
8
Mutant mice and rats lacking D-amino acid oxidase.缺乏 D-氨基酸氧化酶的突变型小鼠和大鼠。
Chem Biodivers. 2010 Jun;7(6):1450-8. doi: 10.1002/cbdv.200900303.
9
Retinal NMDA receptor function and expression are altered in a mouse lacking D-amino acid oxidase.在缺乏 D-氨基酸氧化酶的小鼠中,视网膜 NMDA 受体功能和表达发生改变。
J Neurophysiol. 2013 Dec;110(12):2718-26. doi: 10.1152/jn.00310.2013. Epub 2013 Sep 25.
10
Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.2 型糖尿病患者轻度认知障碍早期诊断的生物标志物:一项多中心、回顾性、巢式病例对照研究。
EBioMedicine. 2016 Feb 6;5:105-13. doi: 10.1016/j.ebiom.2016.02.014. eCollection 2016 Mar.

引用本文的文献

1
and as Modifiers of Age of Onset in Autosomal-Dominant Early-Onset Alzheimer's Disease Caused by the A431E Variant.以及作为由A431E变体引起的常染色体显性早发性阿尔茨海默病发病年龄的修饰因子。
Int J Mol Sci. 2025 Aug 16;26(16):7929. doi: 10.3390/ijms26167929.
2
Glutamatergic and GABAergic metabolite levels in Alzheimer's disease: a systematic review and meta-analysis.阿尔茨海默病中谷氨酸能和γ-氨基丁酸能代谢物水平:一项系统评价和荟萃分析。
BMC Neurol. 2025 Aug 26;25(1):344. doi: 10.1186/s12883-025-04375-2.
3
Interpretable machine learning to evaluate relationships between DAO/DAOA (pLG72) protein data and features in clinical assessments, functional outcome, and cognitive function in schizophrenia patients.

本文引用的文献

1
Expression of D-Amino Acid Oxidase (/) and D-Amino Acid Oxidase Activator () during Development and Aging in the Human Post-mortem Brain.人死后大脑发育和衰老过程中D-氨基酸氧化酶(/)和D-氨基酸氧化酶激活剂(/)的表达
Front Neuroanat. 2017 Apr 6;11:31. doi: 10.3389/fnana.2017.00031. eCollection 2017.
2
d-Amino Acid Levels in Perfused Mouse Brain Tissue and Blood: A Comparative Study.灌注小鼠脑组织和血液中的d-氨基酸水平:一项比较研究。
ACS Chem Neurosci. 2017 Jun 21;8(6):1251-1261. doi: 10.1021/acschemneuro.6b00398. Epub 2017 Feb 16.
3
Haplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive Deficits.
可解释的机器学习,用于评估精神分裂症患者中DAO/DAOA(pLG72)蛋白数据与临床评估、功能结局及认知功能特征之间的关系。
Schizophrenia (Heidelb). 2025 Feb 22;11(1):27. doi: 10.1038/s41537-024-00548-z.
4
Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease.多组学分析揭示了阿尔茨海默病严重程度相关的关键因素。
Alzheimers Res Ther. 2024 Oct 2;16(1):213. doi: 10.1186/s13195-024-01578-6.
5
D-Glutamate production by stressed Escherichia coli gives a clue for the hypothetical induction mechanism of the ALS disease.应激大肠杆菌产生 D-谷氨酸为 ALS 疾病的假设诱导机制提供了线索。
Sci Rep. 2024 Aug 6;14(1):18247. doi: 10.1038/s41598-024-68645-8.
6
Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects.血清丝氨酸和甘氨酸代谢失调可作为虚弱老年患者认知能力下降的预测生物标志物。
Transl Psychiatry. 2024 Jul 9;14(1):281. doi: 10.1038/s41398-024-02991-z.
7
Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions.宿主微生物组在神经精神疾病中的新兴作用:概述及未来方向。
Mol Psychiatry. 2023 Sep;28(9):3625-3637. doi: 10.1038/s41380-023-02287-6. Epub 2023 Oct 16.
8
Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach-A Comprehensive Narrative Review.肠道微生物代谢组学与神经退行性疾病中的菌群失调:益生菌和粪便微生物群移植作为一种治疗方法——全面的叙述性综述。
Int J Mol Sci. 2023 Aug 27;24(17):13294. doi: 10.3390/ijms241713294.
9
Circulating Neurofilament Light Chain Levels Increase with Age and Are Associated with Worse Physical Function and Body Composition in Men but Not in Women.循环神经丝轻链水平随年龄增长而增加,与男性的身体功能和身体成分较差有关,但与女性无关。
Int J Mol Sci. 2023 Aug 13;24(16):12751. doi: 10.3390/ijms241612751.
10
Identification of Bacterial Metabolites Modulating Breast Cancer Cell Proliferation and Epithelial-Mesenchymal Transition.鉴定调节乳腺癌细胞增殖和上皮-间充质转化的细菌代谢物。
Molecules. 2023 Aug 5;28(15):5898. doi: 10.3390/molecules28155898.
D-氨基酸氧化酶基因单倍型与精神分裂症及其神经认知缺陷显著相关。
PLoS One. 2016 Mar 17;11(3):e0150435. doi: 10.1371/journal.pone.0150435. eCollection 2016.
4
Changes in D-aspartic acid and D-glutamic acid levels in the tissues and physiological fluids of mice with various D-aspartate oxidase activities.不同D-天冬氨酸氧化酶活性的小鼠组织和生理体液中D-天冬氨酸和D-谷氨酸水平的变化。
J Pharm Biomed Anal. 2015 Dec 10;116:47-52. doi: 10.1016/j.jpba.2015.05.013. Epub 2015 May 22.
5
d-serine levels in Alzheimer's disease: implications for novel biomarker development.阿尔茨海默病中D-丝氨酸水平:对新型生物标志物开发的启示
Transl Psychiatry. 2015 May 5;5(5):e561. doi: 10.1038/tp.2015.52.
6
Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma.全基因组关联研究 NMDA 受体共激动剂在人脑脊液和血浆中的分布。
Mol Psychiatry. 2015 Dec;20(12):1557-64. doi: 10.1038/mp.2014.190. Epub 2015 Feb 10.
7
Experimental approaches for elucidating co-agonist regulation of NMDA receptor in motor neurons: Therapeutic implications for amyotrophic lateral sclerosis (ALS).阐明运动神经元中NMDA受体共激动剂调节作用的实验方法:对肌萎缩侧索硬化症(ALS)的治疗意义
J Pharm Biomed Anal. 2015 Dec 10;116:2-6. doi: 10.1016/j.jpba.2014.12.040. Epub 2015 Jan 3.
8
NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病中的NMDA神经传递功能障碍。
Curr Pharm Des. 2014;20(32):5169-79. doi: 10.2174/1381612819666140110115603.
9
Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial.苯甲酸盐,一种 D-氨基酸氧化酶抑制剂,用于治疗早期阿尔茨海默病:一项随机、双盲、安慰剂对照试验。
Biol Psychiatry. 2014 May 1;75(9):678-85. doi: 10.1016/j.biopsych.2013.08.010. Epub 2013 Sep 25.
10
Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients.基于毛细管电泳-质谱联用的神经退行性痴呆患者血清和唾液代谢组学分析。
Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6.